Current status of cell-mediated regenerative therapies for human spinal cord injury  

作　　者：Tongming Zhu Qisheng Tang Huasong Gao Yiwen Shen Luping Chen Jianhong Zhu 

机构地区：[1]Department of Neurosurgery,Fudan University Huashan Hospital [2]National Key Laboratory of Medical Neurobiology,Institutes of Brain Science,Shanghai Medical College,Fudan University

出　　处：《Neuroscience Bulletin》2014年第4期671-682,共12页神经科学通报（英文版）

基　　金：supported by grants from the National Natural Science Foundation of China (81271003);he National Basic Research Development Program (973 Program) of China (2010CB945500,2012CB966300,2009CB941100)

摘　　要：During the past decade, significant advances have been made in refinements for regenerative therapies following human spinal cord injury （SCI）. Positive results have been achieved with different types of cells in various clinical studies of SCI. In this review, we summarize recently-completed clinical trials using cell- mediated regenerative therapies for human SCI, together with ongoing trials using neural stem cells. Specifically, clinical studies published in Chinese journals are included. These studies show that current transplantation therapies are relatively safe, and have provided varying degrees of neurological recovery. However, many obstacles exist, hindering the introduction of a specific clinical therapy, including complications and their causes, selection of the target population, and optimization of transplantation material. Despite these and other challenges, with the collaboration of research groups and strong support from various organizations, cell-mediated regenerative therapies will open new perspectives for SCI treatment.During the past decade, significant advances have been made in refinements for regenerative therapies following human spinal cord injury （SCI）. Positive results have been achieved with different types of cells in various clinical studies of SCI. In this review, we summarize recently-completed clinical trials using cell- mediated regenerative therapies for human SCI, together with ongoing trials using neural stem cells. Specifically, clinical studies published in Chinese journals are included. These studies show that current transplantation therapies are relatively safe, and have provided varying degrees of neurological recovery. However, many obstacles exist, hindering the introduction of a specific clinical therapy, including complications and their causes, selection of the target population, and optimization of transplantation material. Despite these and other challenges, with the collaboration of research groups and strong support from various organizations, cell-mediated regenerative therapies will open new perspectives for SCI treatment.

关 键 词：cell-mediated regenerative therapy spinal cord injury clinical trials stem cell 

分 类 号：R651.2[医药卫生—外科学]